ClinConnect ClinConnect Logo
Search / Trial NCT06519227

Translation and Validation of Rivermead Mobility Index in Urdu

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jul 22, 2024

Trial Information

Current as of June 13, 2025

Completed

Keywords

Stroke, Sub Acute Stroke, Translation

ClinConnect Summary

Stroke is the second most common cause of death and the third most common cause of disability in adults worldwide including in Asia. Stroke survivors experience varying degrees of sensory-motor impairments including lack of mobility, reduced functional activity, and poor coordination and balance either due to muscular weakness or spasticity. Mobility is adversely affected after stroke, as patients may face many problems in moving and getting around (walking, stair climbing, etc) .

In stroke rehabilitation, it is recommended to evaluate mobility deficits using standardized tools. RMI is a v...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients with chronic stroke; ischemic or hemorrhagic,
  • Aged between 40 to 80 years who visited the respective rehabilitation center during the study time
  • Those who could read and understand Urdu.
  • Exclusion Criteria

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Lahore, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Binash Afzal, phD*

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported